Carruthers R Michael
Insider CIK 1644467 · NVLS Interim President / CFO · OKUR Director · EWTX Chief Financial Officer · ELEV Director · BBI Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 22,350 | — | $0 | 22,350 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-08-07 | 2026-08-11 | 22,350 | — | $0 | 22,350 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2026-06-04 | 2026-06-08 | 7,650 | — | $0 | 7,650 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2025-08-12 | 2025-08-14 | 161,250 | — | $0 | 161,250 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2025-08-12 | 2025-08-14 | 5,781 | — | $0 | 17,344 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2025-08-12 | 2025-08-14 | 26,875 | — | $0 | 26,875 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2025-08-12 | 2025-08-14 | 1,428 | $13.39 | $19.1K | 86,162 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2025-08-12 | 2025-08-14 | 5,781 | — | $0 | 87,590 | SEC↗ |
| ELEV Elevation Oncology, Inc. | D To issuer deriv | 2025-07-23 | 2025-07-24 | 47,330 | — | $0 | 0 | SEC↗ |
| ELEV Elevation Oncology, Inc. | D To issuer deriv | 2025-07-23 | 2025-07-24 | 35,000 | — | $0 | 0 | SEC↗ |
| ELEV Elevation Oncology, Inc. | D To issuer deriv | 2025-07-23 | 2025-07-24 | 15,619 | — | $0 | 0 | SEC↗ |
| ELEV Elevation Oncology, Inc. | D To issuer deriv | 2025-07-23 | 2025-07-24 | 35,000 | — | $0 | 0 | SEC↗ |
| ELEV Elevation Oncology, Inc. | D To issuer deriv | 2025-07-23 | 2025-07-24 | 31,238 | — | $0 | 0 | SEC↗ |
| ELEV Elevation Oncology, Inc. | A Award deriv | 2025-06-05 | 2025-06-09 | 35,000 | — | $0 | 35,000 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2025-05-28 | 2025-05-30 | 7,650 | — | $0 | 7,650 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2025-05-02 | 2025-05-07 | 1,314 | $16.45 | $21.6K | 81,014 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2025-05-01 | 2025-05-07 | 5,209 | — | $0 | 0 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2025-05-01 | 2025-05-07 | 5,209 | — | $0 | 82,328 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2024-10-11 | 2024-10-16 | 70,000 | — | $0 | 127,122 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2024-10-11 | 2024-10-16 | 70,000 | $0.71 | $49.7K | 76,904 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2024-10-04 | 2024-10-08 | 15,300 | — | $0 | 15,300 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2024-10-04 | 2024-10-08 | 1,324 | — | $0 | 1,324 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award deriv | 2024-10-04 | 2024-10-08 | 1,760 | — | $0 | 1,760 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award | 2024-10-04 | 2024-10-08 | 874 | — | $0 | 874 | SEC↗ |
| OKUR OnKure Therapeutics, Inc. | A Award | 2024-10-04 | 2024-10-08 | 4,065 | — | $0 | 4,939 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2024-09-20 | 2024-09-24 | 96,068 | — | $0 | 40,990 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2024-09-20 | 2024-09-24 | 50,000 | $28.55 | $1.43M | 6,904 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2024-09-20 | 2024-09-24 | 50,000 | $1.93 | $96.5K | 56,904 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2024-09-20 | 2024-09-24 | 24,960 | $28.59 | $713.6K | 6,904 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2024-09-20 | 2024-09-24 | 4,064 | $28.59 | $116.2K | 31,864 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2024-09-20 | 2024-09-24 | 46,068 | $28.59 | $1.32M | 35,928 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2024-09-20 | 2024-09-24 | 46,068 | $1.93 | $88.9K | 81,996 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2024-08-12 | 2024-08-14 | 23,125 | — | $0 | 23,125 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2024-08-12 | 2024-08-14 | 138,750 | — | $0 | 138,750 | SEC↗ |
| ELEV Elevation Oncology, Inc. | A Award deriv | 2024-06-13 | 2024-06-17 | 35,000 | — | $0 | 35,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2024-05-02 | 2024-05-03 | 2,157 | $18.91 | $40.8K | 35,230 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2024-05-01 | 2024-05-03 | 5,208 | — | $0 | 5,209 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2024-05-01 | 2024-05-03 | 5,208 | — | $0 | 37,387 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2024-01-23 | 2024-01-25 | 90,000 | — | $0 | 137,058 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2024-01-23 | 2024-01-25 | 90,000 | $15.78 | $1.42M | 29,024 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2024-01-23 | 2024-01-25 | 90,000 | $1.93 | $173.7K | 119,024 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2023-08-17 | 2023-08-18 | 200,000 | — | $0 | 200,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2023-06-22 | 2023-06-26 | 10,000 | — | $0 | 197,122 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2023-06-22 | 2023-06-26 | 10,000 | $0.71 | $7.1K | 29,024 | SEC↗ |
| ELEV Elevation Oncology, Inc. | A Award deriv | 2023-06-16 | 2023-06-21 | 31,238 | — | $0 | 31,238 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | S Sale | 2023-05-02 | 2023-05-03 | 1,336 | $8.90 | $11.9K | 16,126 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2023-05-01 | 2023-05-03 | 5,208 | — | $0 | 10,417 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2023-05-01 | 2023-05-03 | 5,208 | — | $0 | 17,462 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2022-08-08 | 2022-08-10 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ELEV Elevation Oncology, Inc. | A Award deriv | 2022-06-17 | 2022-06-22 | 15,619 | — | $0 | 15,619 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise deriv | 2022-05-23 | 2022-05-25 | 9,000 | $0.71 | $6.4K | 207,122 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | M Exercise | 2022-05-23 | 2022-05-25 | 9,000 | $0.71 | $6.4K | 12,000 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2022-05-01 | 2022-05-03 | 15,625 | — | $0 | 15,625 | SEC↗ |
| EWTX Edgewise Therapeutics, Inc | A Award deriv | 2021-08-17 | 2021-08-19 | 120,000 | — | $0 | 120,000 | SEC↗ |
| BBI Brickell Biotech, Inc. | A Award deriv | 2020-03-16 | 2020-03-18 | 10,000 | $1.54 | $15.4K | 10,000 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | A Award deriv | 2017-01-12 | 2017-01-23 | 200,000 | — | $0 | 200,000 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | P Buy | 2016-12-02 | 2016-12-05 | 24,000 | $2.09 | $50.2K | 24,000 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | A Award deriv | 2016-09-12 | 2016-09-14 | 110,000 | — | $0 | 110,000 | SEC↗ |
| NVLS Nivalis Therapeutics, Inc. | A Award deriv | 2015-09-11 | 2015-09-15 | 55,400 | — | $0 | 55,400 | SEC↗ |